In unselected breast cancer cohorts, the prevalence of BRCA1 and BRCA2 P/LP variants is generally reported to be between 1.8% and 2.6% for BRCA1 and 1.3%–2.1% for BRCA2 (7–9). The gene discussed is BRCA2; the disease is breast carcinoma.